Sanofi names Genzyme chief executive
Sanofi has appointed David Meeker as chief executive officer of its biotechnology subsidiary Genzyme Corp. Plans call for Meeker to take the CEO reins at Genzyme on Nov. 1, Sanofi said Monday.
Supplier News
Watson to market lower-dose testosterone patch
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Authorized generic pact signed by Prasco, Eli Lilly
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
Bayer category manager joins Emerson Group
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
Abbott to split into two companies
Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
It’s official: Matrix renamed Mylan Laboratories
Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd. The name change is effective immediately, the company said.
Senior management changes at Bristol-Myers Squibb
Bristol-Myers Squibb Co. has announced some executive moves within its senior management team. The company said Wednesday that Giovanni Caforio has been promoted to president of U.S. Pharmaceuticals. He previously was senior vice president of oncology and immunology global commercialization.
Scope Dual-Blast leads bad breath crusade
Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.
Prasco to distribute Aspen branded drugs
Prasco Laboratories has been named the exclusive U.S. distributor and pharmaceutical services provider for Aspen Global branded prescription drugs. Prasco said Tuesday that Aspen Global, a subsidiary of South Africa-based Aspen Pharmacare Holdings Ltd., is Africa’s largest pharmaceutical company.
Sandoz to add Falcon eye products from Alcon
The ophthalmic and otic products of Falcon Pharmaceuticals Ltd., the U.S. generics business of Alcon Inc., are being brought under the Sandoz umbrella. Sandoz, the generic pharmaceuticals arm of Novartis, said Tuesday that the Falcon products are slated to become part of its U.S.
Par Pharmaceutical picks up three Teva generics
Par Pharmaceutical Cos. has acquired rights to three products from Teva Pharmaceuticals in connection with Teva’s acquisition of Cephalon.
Archimedes rolls out Lazanda
Archimedes Pharma Ltd. and its subsidiary, Archimedes Pharma U.S. Inc., have rolled out Lazanda fentanyl nasal spray to U.S. pharmacies.
Kirby Lester unveils Rx automation ‘one-two punch’
Kirby Lester has introduced the Kirby Lester 60/30 Combination, a solution that the company bills as packing "a one-two pharmacy automation punch.
Lannett ships three new generics
Lannett Co. has launched a trio of new generic drug products recently approved by the Food and Drug Administration. The new generic medications include two appetite suppressants — diethylpropion tablets (25 mg) and phentermine HCI capsules (37.
Teva wraps up Cephalon acquisition
Teva Pharmaceutical Industries Ltd. has closed its acquisition of Cephalon Inc. Teva said that as of Friday, Cephalon became a wholly owned subsidiary of and ceased to be traded on Nasdaq. The two pharmaceutical companies unveiled the $6.8 billion deal this past spring.
With retirements, Eli Lilly promotes senior staff
Eli Lilly and Co. is promoting a trio of senior executives with the announcement that longtime company Bryce Carmine and Frank Deane plan to retire. The pharmaceutical company said this week that Carmine and Deane are slated to retire as of Dec. 31.